WEEKLY RESEARCH HIGHLIGHT Updated
Cancer immunity · Preclinical research

Immune cells can
help—or hurt.

The problem

A cancer treatment that removes certain immune cells might help some tumors but harm others.

What the study shows

In mice, removing CD4 immune cells slowed melanoma and kidney tumors but made liver tumors grow faster. The difference was linked to a tumor marker called MHC II. Researchers also found a related pattern in human cancer data, but this has not been tested as a way to choose patient treatment.



One study. A step toward better care.

Removing CD4 cells changed tumor growth in mice

B16 melanoma↓ Slower growth
Renca kidney cancer↓ Slower growth
Hepa1-6 liver cancer↑ Faster growth

MHC II helped explain the opposite effects

Low tumor MHC II↓ Growth after CD4 removal
High tumor MHC II↑ Growth after CD4 removal
Qualitative summary of mouse experiments (Figs. 1, 5 and 6). Arrows show the direction of tumor-growth changes, not their size. Human cancer-data findings were associations, not proof of treatment benefit.

Study authors

Yanping Wang, Minhyung Kim, Shengchen Su, Lahiruni Halwatura, Sungyong You, Hyung L. Kim.

Read the paper ↗
Study details & source

Using major histocompatibility complex (MHC) II expression to predict antitumor response to CD4+ lymphocyte depletion. Scientific Reports. 2025 Feb 14;15:5469. doi:10.1038/s41598-025-88972-8. Open full text.

Syngeneic mouse models included B16 melanoma, Renca kidney cancer, and Hepa1-6 liver cancer. CD4-depleting antibodies reduced tumor growth in B16 and Renca but increased growth in Hepa1-6. Experimentally altering tumor MHC II expression helped establish the mechanism. This is not a clinical trial.

Exploratory TCGA pan-cancer analysis found that higher CD4 expression correlated with better progression-free survival in tumors with high MHC II and low MHC I (p=0.0217); overall survival showed a nonsignificant trend (p=0.0770). These correlations do not demonstrate that depletion or preservation of CD4 cells improves patient outcomes.

Original two-panel schematic summarizes reported experimental directions without copying publisher artwork. Source: PMID 39953106 (Wang et al.); the article is distributed under CC BY-NC-ND 4.0.